GreenLight Biosciences Holdings
GRNA · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $66 | $156 | $323 | $272 |
| - Cash | $32 | $68 | $98 | $44 |
| + Debt | $77 | $80 | $30 | $32 |
| Enterprise Value | $111 | $168 | $254 | $260 |
| Revenue | $4 | $3 | $2 | $2 |
| % Growth | 29.6% | 74.5% | -3.4% | – |
| Gross Profit | $4 | $3 | $2 | $2 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$25 | -$35 | -$34 | -$51 |
| % Margin | -663.7% | -1,194.1% | -2,027.2% | -2,890.8% |
| Net Income | -$28 | -$40 | -$38 | -$52 |
| % Margin | -734.1% | -1,356.6% | -2,259.2% | -2,968.6% |
| EPS Diluted | -0.18 | -0.3 | -0.27 | -0.42 |
| % Growth | 40% | -11.1% | 35.7% | – |
| Operating Cash Flow | -$31 | -$25 | -$40 | -$23 |
| Capital Expenditures | -$2 | -$4 | -$10 | -$13 |
| Free Cash Flow | -$33 | -$28 | -$50 | -$35 |